深厚的历史底蕴

公司历史

看看我们在170余年药店服务中取得的成就

1892 opening of a Boots store in Pelham Street, Nottingham.
1800年代
1849年

约翰·博特(John Boot)在英国诺丁汉鹅门(Goose Gate)开设了第一家 “博姿”(Boots)门店销售草本药

1870年

“博姿”(Boots)业务在创始人约翰·博特(John Boot)的儿子杰西·博特(Jesse Boot)手中开始发展壮大

1900年代
1901年

老查尔斯·沃尔格林(Charles R. Walgreen Sr.)买下他在美国芝加哥作药剂师的那家药店S.

1909年

“沃尔格林” 公司(Walgreen Co.)成立,并开设了第二家门店,药店连锁自此起步

1922年

“沃尔格林”(Walgreens)发明了麦芽奶昔

1927年

“沃尔格林”(Walgreens)股票公开交易

“博姿”(Boots)买下诺丁汉的比斯顿地块

1933年

“博姿”(Boots)的第1000家门店在英国开张

1934年

“沃尔格林”(Walgreens)股票在纽约证券交易所上市

1935年

“博姿”(Boots)推出No7彩妆产品

1938年

“联化集团”(UniChem group)在英国成立,为独立药店批发医药产品

1950年

“沃尔格林”(Walgreens)开始转型为自助式门店

“摩斯药店”(Moss Chemists)处方服务配送车投入运营

1951年

第一家 “博姿”(Boots)自助服务门店在英国伦敦进行试点

1960年

“沃尔格林”(Walgreens)进入波多黎各市场

1968年

“沃尔格林”(Walgreens)开美国大药店连锁的先例,将处方药放入防止儿童误服的药盒中

1969年

“博姿”(Boots)在英国推出消炎药艾布洛芬(又称布洛芬)

1977年

斯德法诺·佩西纳(Stefano Pessina)在意大利创立医药批发公司 “联合医药”(Alleanza Farmaceutica)

1981年

爱荷华州的“沃尔格林”(Walgreens)药店安装了第一台药店内部互通电脑

1982年

奥内拉·芭拉(Ornella Barra)在意大利创立了医药批发公司 “药”(Di Pharma)

1984年

“沃尔格林”(Walgreens)开设第1000家门店

1991年

“沃尔格林”(Walgreens)开设了第一家提供“得来速”服务(免下车购买)的药店

“联化” 公司(UniChem)收购了英国的 “摩斯药店”(Moss Chemists)

意大利“联合医药”(Alleanza Salute)与法国医药批发商 “ERPI” 和 “IFP”合并,成立了 “联合健康” 集团(Alliance Santé group)

1997年

“联化”(UniChem)与 “联合健康”(Alliance Santé)合并,成立了 “联合联化”(Alliance UniChem)

1998年

“联合联化”(Alliance UniChem)收购了西班牙 “S.A.F.A.”公司

“博姿”(Boots)成为爱尔兰最大的零售药店连锁

1999年

“沃尔格林”(Walgreens)推出线上药店Walgreens.com

2000年代
2002年

“沃尔格林”(Walgreens)成为第一家全店提供多语种处方标签的药店连锁

“联合联化”(Alliance UniChem)增持 “荷戴夫”(Hedef)股权至50%

2004年

“联合联化”(Alliance UniChem)收购了德国医药批发公司 “安在格”(ANZAG)29.99%的股权

2006年

“联合联化”(Alliance UniChem)与 “博姿集团”(Boots Group)合并,成立 “联合博姿”(Alliance Boots)

“沃尔格林”(Walgreens)收购了 “快乐哈利”(Happy Harry’s)药店连锁

“沃尔格林”(Walgreens)开始提供门店内保健诊所服务

2007年

“联合博姿”(Alliance Boots)旗下的批发业务进行品牌重塑、更名为 “联合医药”(Alliance Healthcare)品牌

“联合博姿”(Alliance Boots)私有化

“沃尔格林”(Walgreens)在夏威夷开设了第一家门店;同年,第6000家门店在路易斯安那州开张

“沃尔格林”(Walgreens)收购了 “关护健康系统”(Take Care Health Systems)和 “奥普逊关护”(Option Care)

英国市场超过1000家 “联合药店”(Alliance Pharmacy)进行品牌重塑,更名为 “您身边的博姿药店”(Your local Boots pharmacy)

2009年

“博姿眼镜”(Boots Opticians)和 “多兰·阿池森”(Dollond & Aitchison)合并成立英国第二大眼镜连锁店

2010年

“联合博姿”(Alliance Boots)成为 “荷戴夫联合”(Hedef Alliance)的大股东

“联合博姿”(Alliance Boots)成为 “安在格”(ANZAG)的大股东

“沃尔格林”(Walgreens)完成收购总部位于纽约的 “杜安雷德”(Duane Reade)药店连锁

“沃尔格林”(Walgreens)开设第一家 “优质体验式”(Well Experience format)门店

2012年

“沃尔格林”(Walgreens)收购“联合博姿”(Alliance Boots)45%的股权,这是双方战略合作伙伴合作的第一步,以创建全球首家以药店为主导的世界级医药保健企业

“沃尔格林”(Walgreens)的第8000家门店在洛杉矶开张,同年收购了美国中南部的一家药店连锁 “美国之药”(USA Drug)

“沃尔格林”(Walgreens)、“联合博姿”(Alliance Boots)在瑞士伯尔尼成立合资公司 “沃尔格林博姿联合发展”(Walgreens Boots Alliance Development)

2013年

“沃尔格林”(Walgreens)和“联合博姿”(Alliance Boots)宣布与 “美源伯根”(AmerisourceBergen)结成长期战略伙伴关系,合作寻求全球供应链方面的发展机会

2014年

“沃尔格林”(Walgreens)行权,完成与“联合博姿”(Alliance Boots)战略合作伙伴的第二步,实现完全合并,成立“沃博联”(Walgreens Boots Alliance)

“联合博姿”(Alliance Boots)完成收购“南京医药股份有限公司”(Nanjing Pharmaceutical Company Limited)12%股权;后者是一家中国主要的医药批发商

“联合博姿”(Alliance Boots)完成收购墨西哥的贝纳维达药店(Farmacias Benavides)和智利的阿乎马达药店(Farmacias Ahumada)

2017年

“沃博联” 与 “法雷瓦” 达成长期全球供应链协议

“沃尔格林” 获得美国监管方批准收购1932家 “莱爱德” 药店

2018年

“沃博联” 成为30家股票被纳入道琼斯工业指数的公司之一

7月,“沃博联” 完成对 “国药控股国大药房” 40%少数股权的收购。“国大药房” 是中国领先的零售药店连锁

9月,“沃博联” 和 “阿里巴巴” 合作,在阿里巴巴针对国际品牌和零售商业务的B2C天猫平台上开设博姿旗舰店,将博姿的代表性美容品牌产品引入中国,通过阿里巴巴的平台触达五亿多中国消费者

2020

In March, Walgreens pledged in a White House meeting its commitment to aid the Administration in providing access to COVID-19 testing.

In December, a Walgreens pharmacist administered one of the first COVID-19 vaccines in the U.S., in a long-term care facility, as the company continued to play a growing and integral role as part of the nationwide response effort.

2020

In July, WBA and VillageMD announced that Walgreens would be the first national pharmacy chain to offer full-service doctor offices co-located at stores.

2020

In November, Walgreens announced the launch of myWalgreens, a complete reinvention of its customer loyalty program to offer customers extensive new benefits.

2021

In January, WBA made a majority investment in iA, a leading-edge provider of software enabled pharmacy automation solutions. The investment represents an important step to enable pharmacists to expand their role in patient care.

2021

In April, Walgreens opened its first micro-fulfillment center using automation technology to fill prescriptions, reducing workload in Walgreens retail pharmacies.

2021

In April, WBA launched the No7 Beauty Company, a consumer-led beauty business creating beauty brands for every skin type, ethnicity, age and texture that everyone can trust.

2021年

6月“沃博联”完成交割,将旗下“联合医药”(Alliance Healthcare)业务出售给“美源伯根”(AmerisourceBergen Corporation)。这一交易使“沃博联”能进一步聚焦于发展其核心的零售药店业务,给顾客和患者提供带去更多创新的保健服务品种

2021

In October, WBA announced its new consumer-centric healthcare strategy to drive sustainable, long-term profitable growth. The strategy features the launch of the company’s Walgreens Health business segment (now known as U.S. Healthcare), enabled by investments in VillageMD, CareCentrix and Shields Health Solutions (Shields), accelerating the company’s capabilities in primary care, post-acute care and home care.

2022

In February, WBA announced the completion of the acquisition of the remaining 30% equity stake in its German pharmaceutical wholesale joint venture with McKesson Corporation. As a result, WBA assumed full ownership of the combined GEHE and Alliance Healthcare businesses in Germany.

2022

In June, Walgreens announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.

2022

In November, VillageMD announced that it had entered a definitive agreement to acquire Summit Health-CityMD. With investments from WBA and Evernorth, the combined company created one of the largest independent provider groups in the U.S. It also enhanced WBA’s robust portfolio of leading, integrated healthcare offerings across the care continuum.

2022

In December, Walgreens launched 24-hour same day delivery, offering the most retail items for around the clock delivery across the country.

2022

In December, WBA acquired full ownership of Shields. An industry leader in integrated, health system-owned specialty pharmacy care, Shields is a core asset as part of the WBA U.S. Healthcare segment.

2023

In March, WBA acquired full ownership of CareCentrix, expanding its reach into the growing homecare sector and advancing its healthcare long-term growth strategy.